Position in NKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,332,755
-$322,549 QoQ
Shares Held
1,177,652
-32.0% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 136 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. NKTX ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in NKTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,332,755 | 1,177,652 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,655,304 | 1,732,372 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,148,740 | 1,702,022 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,370,309 | 1,145,077 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,155,977 | 696,372 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,493,292 | 811,572 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,885,116 | 757,075 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,996,909 | 884,272 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,395,073 | 912,872 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,808,766 | 814,872 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,341,295 | 657,772 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $712,475 | 512,572 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $709,560 | 324,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $863,715 | 243,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,399,863 | 233,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,868,880 | 218,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,996,992 | 405,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,662,920 | 234,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,116,765 | 137,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $850,986 | 30,600 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||